CompletedNot applicableNCT04122235
The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study
Studying Vulvar carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sorlandet Hospital HF
- Principal Investigator
- Ingvild Vistad, MD, PhDSorlandet Hospital HF
- Intervention
- LETSGO follow-up(other)
- Enrollment
- 755 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2019 – 2026
Study locations (12)
- Innlandet Hospital Gjøvik, Gjøvik, Oppland, Norway
- Sorlandet Hospital, Kristiansand, Vest Agder, Norway
- Sørlandet hospital Arendal, Arendal, Norway
- Nordland Hospital, Bodø, Norway
- Innlandet Hospital Lillehammer, Lillehammer, Norway
- Akershus University Hospital, Lørenskog, Norway
- Oslo University Hospital, Oslo, Norway
- Østfold Hospital Trust, Sarpsborg, Norway
- Stavanger University Hospital, Stavanger, Norway
- University Hospital of North Norway, Tromsø, Norway
- St.Olavs Hospital, Trondheim, Norway
- Vestfold Hospital Trust, Tønsberg, Norway
Collaborators
University of Agder · Uppsala University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04122235 on ClinicalTrials.govOther trials for Vulvar carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06447064Cancer Loyalty Card Study 2 (CLOCS-2)Imperial College London
- RECRUITINGNCT07380698The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological CancerCukurova University
- ENROLLING BY INVITATIONNANCT07023601International Prospective Multicentre Study That Evaluate the Sentinel Lymph Node Detection Rate in Patients With First Local Recurrent Scamous Cell Carcinoma of the Vulva.Hospital Universitario La Paz
- RECRUITINGPHASE2NCT05903833Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or RadiotherapyAGO Research GmbH
- RECRUITINGNANCT05576831STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide ExcisionBritish Columbia Cancer Agency
- RECRUITINGNANCT06495554Danish Vulva Cancer Recurrence StudyUniversity of Aarhus
- RECRUITINGNANCT06264167NODE (groiN ultrasOunD cancEr)Queensland Centre for Gynaecological Cancer
- ACTIVE NOT RECRUITINGNANCT06694116Charcoal Carbon Black Dye Use in Sentinel Lymph Node Mapping in Early Stage Vulvar CancerIstanbul University